Read-Gene S.A.   Report issue

For profit
Founded: Szczecin Poland (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2014
NCT04014283
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Read-Gene S.A.

Active Ingredients

Drugs in Other Trials (1)

selenium (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1